Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.
A Look Into Energy Sector Value Stocks
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the…
Oppenheimer Downgrades CinCor Pharma to Perform
Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.
Related Posts
Strike Three! Apple Prompts YouTube To Remove Fan Channel Filled With Rare, Decades-Old WWDC Videos
Apple Inc. (NASDAQ: AAPL) prompted a takedown of a fan's archival YouTube channel — but is apparently not making the company's history readily available to fans.
Ormat Signs Agreements To Develop 50MW Geothermal Power Plant In New Zealand
Ormat Technologies, Inc. (Ormat), a leading geothermal, energy storage, photovoltaic (PV), solar and recovered energy power company, today announced the signing of agreements with Eastland Generation Limited (EGL) to
Deutsche Bank Upgrades Estee Lauder Cos to Buy, Raises Price Target to $266
Deutsche Bank analyst Steve Powers upgrades Estee Lauder Cos (NYSE:EL) from Hold to Buy and raises the price target from $209 to $266.